179 related articles for article (PubMed ID: 33763449)
1. Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma.
Li H; Wang X; Zhang M; Wang M; Zhang J; Ma S
Front Mol Biosci; 2020; 7():602068. PubMed ID: 33763449
[TBL] [Abstract][Full Text] [Related]
2. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.
Bitu CC; Destro MF; Carrera M; da Silva SD; Graner E; Kowalski LP; Soares FA; Coletta RD
BMC Cancer; 2012 Apr; 12():146. PubMed ID: 22498108
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma.
Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA
Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333
[TBL] [Abstract][Full Text] [Related]
4. HOXA1 is a radioresistance marker in multiple cancer types.
He L; Liang M; Guo W; Liu J; Yu Y
Front Oncol; 2022; 12():965427. PubMed ID: 36119466
[TBL] [Abstract][Full Text] [Related]
5.
Sorroche BP; Miranda KC; Beltrami CM; Arantes LMRB; Kowalski LP; Marchi FA; Rogatto SR; Almeida JD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473236
[TBL] [Abstract][Full Text] [Related]
6. High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.
Lu T; Zheng Y; Gong X; Lv Q; Chen J; Tu Z; Lin S; Pan J; Guo Q; Li J
Front Oncol; 2021; 11():608842. PubMed ID: 33763352
[No Abstract] [Full Text] [Related]
7. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
9. Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.
Zhang Z; Liu R; Jin R; Fan Y; Li T; Shuai Y; Li X; Wang X; Luo J
Front Oncol; 2019; 9():434. PubMed ID: 31214495
[No Abstract] [Full Text] [Related]
10. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
11. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylated SPANXA1/A2 promotes the metastasis of head and neck squamous cell carcinoma.
Li J; Bo H; Zhu F; Li Q; Chen T; Lei S; Fan L
Med Oncol; 2020 Nov; 37(12):112. PubMed ID: 33175201
[TBL] [Abstract][Full Text] [Related]
13. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.
Wu X; Li J; Yan T; Ke X; Li X; Zhu Y; Yang J; Li Z
Cancer Cell Int; 2021 Jul; 21(1):393. PubMed ID: 34303375
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Methylation and Immune Microenvironment Are Associated With Overexpressed Fibronectin 1: A Diagnostic and Prognostic Target in Head and Neck Squamous Cell Carcinoma.
Sheng S; Guo B; Wang Z; Zhang Z; Zhou J; Huo Z
Front Mol Biosci; 2021; 8():753563. PubMed ID: 34746236
[No Abstract] [Full Text] [Related]
15. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
16. Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Jiang Y; Li Y; Ge H; Wu Y; Zhang Y; Guo S; Zhang P; Cheng J; Wang Y
J Oral Pathol Med; 2021 Nov; 50(10):1040-1049. PubMed ID: 34358365
[TBL] [Abstract][Full Text] [Related]
17. HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer.
Liu J; Liu J; Lu X
Exp Ther Med; 2019 Mar; 17(3):1896-1902. PubMed ID: 30783466
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
[TBL] [Abstract][Full Text] [Related]
19. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
20. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
